A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SGLT-2 / sodium-glucose transport protein 2

[Related PubMed/MEDLINE]
Total Number of Papers: 9
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SGLT-2  (>> Co-occurring Abbreviation)
Long Form:   sodium-glucose transport protein 2
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. AAAs, PPE
2022 Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. GLP-1
2022 The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis. DKA, DM
2021 Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report. ---
2021 In type 2 diabetes, SGLT2 inhibitors reduce all-cause, but not cardiovascular, mortality vs. GLP-1 RAs. GLP-1
2021 Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States. ---
2021 Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. GLP-1
2021 The effect of sodium-glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studies. RCTs
2018 Diabetes Mellitus and Cardiovascular Disease: An Evidence-Based Review of Provincial Formulary Coverage. GLP-1, T2DM